Atherton, California
United States
55
2024-06-06
The entities that hold a legal rights for patent applications filed by inventor Neff Thomas B.:
Thomas B. Neff from Atherton, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ENHANCED ERYTHROPOIESIS AND IRON METABOLISM
#2 | 2024-03-07CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES
#3 | 2021-12-02METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#4 | 2021-07-29CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES
#5 | 2021-04-22Enhanced erythropoiesis and iron metabolism
#6 | 2021-04-15Enhanced erythropoiesis and iron metabolism
#7 | 2019-01-24CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES
#8 | 2018-07-26Enhanced erythropoiesis and iron metabolism
#9 | 2018-06-14Enhanced erythropoiesis and iron metabolism
#10 | 2017-09-21Enhanced erythropoiesis and iron metabolism
#11 | 2017-08-10Enhanced erythropoiesis and iron metabolism
#12 | 2017-08-03Enhanced Erythropoiesis and Iron Metabolism
#13 | 2017-08-03Enhanced Erythropoiesis and Iron Metabolism
#14 | 2016-09-08Connective Tissue Growth Factor Antibodies
#15 | 2016-01-28CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES
#16 | 2015-09-03Enhanced erythropoiesis and iron metabolism
#17 | 2015-05-07METHODS FOR TREATING ANEMIA
#18 | 2015-03-19METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#19 | 2015-01-15TREATMENT FOR HIGH CHOLESTEROL
#20 | 2014-10-16Therapeutic Method
#21 | 2014-05-22Enhanced Erythropoiesis and Iron Metabolism
#22 | 2014-05-08Therapeutic method
#23 | 2013-09-19Stabilization of Hypoxia Inducible Factor (HIF) Alpha
#24 | 2013-08-15Treatments for cancer
#25 | 2013-08-08Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
#26 | 2012-06-14Methods for improving kidney function
#27 | 2011-10-27METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS
#28 | 2011-07-07Stabilization of hypoxia inducible factor (HIF) alpha
#29 | 2011-04-21Connective tissue growth factor antibodies
#30 | 2011-02-17Enhanced erythropoiesis and iron metabolism
#31 | 2011-02-17Enhanced erythropoiesis and iron metabolism
#32 | 2010-12-30Treatment method for anemia
#33 | 2010-11-18Diabetic nephropathy therapies
#34 | 2010-11-04Enhanced erythropoiesis and iron metabolism
#35 | 2010-11-04Enhanced erythropoiesis and iron metabolism
#36 | 2010-07-01Fat regulation
#37 | 2010-06-24CONNECTIVE TISSUE GROWTH FACTOR FRAGMENTS AND METHODS AND USES THEREOF
#38 | 2009-11-17Fat regulation
#39 | 2009-06-04Recombinant gelatins
#40 | 2009-01-15Antibodies that bind to a portion of the VWC domain of connective tissue growth factor
#41 | 2008-08-28Treatments for pancreatic cancer metastases
#42 | 2008-07-29Connective tissue growth factor antibodies
#43 | 2006-12-07Treatment method for anemia
#44 | 2006-11-30Stabilization of hypoxia inducible factor (HIF) alpha
#45 | 2006-11-16Stabilization of hypoxia inducible factor (HIF) alpha
#46 | 2006-11-16Stabilization of hypoxia inducible factor (HIF) alpha
#47 | 2006-10-03Connective tissue growth factor fragments and methods and uses thereof
#48 | 2006-08-17Methods of increasing endogenous erythropoietin (EPO)
#49 | 2006-08-10Methods of increasing endogenous erythropoietin (EPO)
#50 | 2006-08-10Methods of increasing endogenous erythropoietin (EPO)
#51 | 2006-01-31Recombinant gelatins
#52 | 2005-12-08Treatments for cancer
#53 | 2005-10-13Recombinant gelatins
#54 | 2005-09-29Diabetic nephropathy therapies
#55 | 2005-01-27Enhanced erythropoiesis and iron metabolism
378701 ⎘